このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Spinal Cord Stimulation Combined With Brain-Computer Interface Rehabilitation to Improve Motor Function After Stroke (SCS-BCI Rehab)

2026年11月10日 更新者:Qingdao Central Hospital

A Study on the Efficacy Evaluation of Spinal Cord Stimulation Combined With a Brain-Computer Interface for Improving Motor Function in Patients With Post-Stroke Hemiplegia Based on Multi-Source Neurophysiological Data

This study evaluates the effects of spinal cord stimulation (SCS) combined with brain-computer interface (BCI)-assisted rehabilitation on motor function in patients with post-stroke hemiplegia using multisource neurophysiological data. In this single-group study with repeated measurements, participants undergo four weeks of SCS combined with BCI-driven upper- and lower-limb rehabilitation. Immediate motor performance is compared between SCS ON and OFF conditions under standardized tasks. Changes in motor function and multisource neurophysiological and kinematic measures are also assessed before and after rehabilitation to characterize treatment responses and explore their relationships with clinical motor improvement.

調査の概要

状態

募集

条件

介入・治療

詳細な説明

This is a single-group study using a within-participant pre-post design with repeated measurements. The study enrolls patients with post-stroke hemiplegia who meet the clinical indications for spinal cord stimulation (SCS) surgery and require SCS treatment. Following preoperative baseline assessment, participants undergo SCS implantation based on clinical indications, followed by stimulation parameter adjustment, individualized brain-computer interface (BCI) model calibration, and rehabilitation device setup.

The study includes four weeks of SCS combined with BCI-assisted synchronized upper- and lower-limb active rehabilitation. The first week includes postoperative recovery, stimulation parameter adjustment, and early closed-loop training. During rehabilitation, the BCI system identifies motor intentions from electroencephalography (EEG) signals in real time and drives upper- and lower-limb rehabilitation robots to provide corresponding assisted movements, establishing a closed-loop process integrating motor intention, robotic assistance, and sensorimotor feedback. Training is planned for three to five sessions per week, with 45-60 minutes of effective training per session.

Repeated measurements under SCS ON and OFF conditions are performed to evaluate the immediate effects of stimulation. With BCI closed-loop tasks, robotic assistance settings, and movement requirements held constant, motor performance during affected upper-limb, lower-limb, and synchronized upper- and lower-limb tasks is compared between SCS OFF and ON conditions. At least one standardized ON/OFF comparison is conducted each week during the intervention period.

Assessments are conducted at the preoperative baseline (T0), postoperative immediate-effect assessment (T1), week-2 mid-intervention assessment (T2), week-4 endpoint assessment (T3), and follow-up (T4). Clinical motor function assessments and multisource data, including EEG, functional near-infrared spectroscopy, electromyography, electrodermal activity, upper- and lower-limb kinematics, and BCI control logs, are used to evaluate changes in motor function, cortical activity, muscle activation patterns, interlimb coordination, and BCI closed-loop performance. Relationships between objective measures and improvements in clinical motor function are also examined.

研究の種類

観察的

入学 (推定)

40

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Shandong
      • Qingdao、Shandong、中国、266033
        • 募集
        • Qingdao Central Hospital, University of Health and Rehabilitation Sciences
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~75年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

The study population consists of adults aged 18 to 75 years with imaging-confirmed ischemic or hemorrhagic stroke and unilateral hemiplegia. Participants must meet the clinical indications for spinal cord stimulation (SCS) implantation and be scheduled to undergo SCS surgery for clinical reasons. They must be clinically stable and able to complete brain-computer interface (BCI) calibration, synchronized upper- and lower-limb rehabilitation assessments, and multisource physiological data collection

説明

Inclusion Criteria

  1. Age 18-75 years.
  2. Patients who meet the clinical indications for SCS surgery, require SCS to improve their condition, and plan to undergo the procedure at the study center.
  3. Ischemic or hemorrhagic stroke confirmed by CT or MRI.
  4. Unilateral hemiplegia with assessable motor dysfunction in both the affected upper and lower limbs.
  5. Stable clinical condition and ability to cooperate with SCS implantation surgery, BCI calibration, synchronized upper- and lower-limb robotic rehabilitation, and collection of all multisource physiological data.
  6. Adequate cognitive and comprehension abilities to complete motor imagery or motor-attempt tasks and meet the requirements for BCI modeling and closed-loop control.
  7. Meets the clinical indications for epidural SCS implantation based on neurosurgical evaluation.
  8. Body size, joint range of motion, and tolerance of sitting or standing are compatible with the safe use of upper- and lower-limb rehabilitation robots.
  9. Written informed consent signed by the patient or their legally authorized representative.

Exclusion Criteria

  1. Severe cognitive impairment, complete aphasia, or severe unilateral spatial neglect that prevents completion of all study tasks.
  2. Uncontrolled epilepsy or frequent seizures during the previous three months.
  3. Contraindications to surgery or anesthesia, including severe cardiopulmonary disease, coagulation disorders, or active systemic infection.
  4. Implanted electronic medical devices with electromagnetic compatibility conflicts involving the SCS system, EEG/fNIRS brain recording devices, or rehabilitation robots.
  5. Severe limb contracture, persistent severe pain, structural joint injury, or positional intolerance that prevents standardized synchronized rehabilitation training.
  6. Skin lesions or skin disorders on the head or limbs that prevent the use of EEG, fNIRS, EMG, or electrodermal sensors.
  7. Any other condition judged by the investigator to make participation in the study inappropriate.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
SCS Combined With BCI-Assisted Synchronized Upper- and Lower-Limb Active Rehabilitation

All participants receive SCS combined with EEG-driven BCI-assisted synchronized upper- and lower-limb active rehabilitation. After baseline assessment, SCS implantation, and parameter adjustment, participants complete four weeks of training and weekly SCS ON/OFF comparisons under consistent BCI tasks and robotic assistance settings. Clinical motor outcomes, multisource neurophysiological signals, kinematics, and BCI control logs are collected

An epidural SCS system is used, comprising stimulation electrodes, a pulse generator or external stimulator, a programming system, and an event recording system. The clinical team determines the stimulation target according to motor impairments, surgical safety, and the established treatment plan. Standardized SCS OFF and ON comparisons are performed under consistent BCI tasks and robotic assistance settings, with stimulation parameters, motor performance, and related physiological data recorded

The BCI active rehabilitation system identifies motor intention during imagery or attempted movement from real-time EEG signals and triggers corresponding assisted movements using upper- and lower-limb rehabilitation robots, forming a closed loop between motor intention, sensory feedback, and limb movement. Rehabilitation continues for four weeks, three to five times per week (preferably five), with 45-60 minutes of effective training per session. At least one standardized SCS ON/OFF comparison is performed weekly

他の名前:
  • EEG-Driven BCI-Assisted Synchronized Upper- and Lower-Limb Active Rehabilitation

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Difference in Immediate Motor Task Performance Between SCS ON and OFF Conditions
時間枠:Intervention weeks 1-4 (T1-T3)

Motor performance during affected upper-limb, lower-limb, and synchronized upper- and lower-limb tasks is compared between SCS ON and OFF conditions, with BCI closed-loop mode and robotic assistance parameters kept consistent, to evaluate the immediate effects of SCS

Intervention weeks 1-4 (T1-T3)
Change in Upper- and Lower-Extremity Fugl-Meyer Assessment Scores
時間枠:Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)

The Fugl-Meyer Assessment (FMA) is used to evaluate changes in upper- and lower-extremity motor function separately before and after four weeks of combined rehabilitation

Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)
Pearson/Spearman Correlation Between Multisource Objective Measures and Clinical Motor Improvement
時間枠:Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)

Pearson or Spearman correlation analysis will be performed to examine the correlation between multisource neurophysiological measures (EEG, fNIRS, EMG, electrodermal), kinematic parameters, and BCI closed-loop performance metrics, and the change in Fugl-Meyer Assessment (FMA) score, to identify objective features linked to the effects of combined rehabilitation.

Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in 10-Meter Walk Test Speed
時間枠:T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

Walking ability is assessed using the 10-Meter Walk Test.

T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
Change in Modified Ashworth Scale Scores
時間枠:T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

Changes in spasticity of the affected upper and lower limbs are assessed using the Modified Ashworth Scale

T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
Changes in Motor-Related EEG Features
時間枠:T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

Changes in movement-related EEG rhythms, movement-related cortical potentials, and motor intention decoding features are assessed

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
Changes in Motor-Area fNIRS Hemodynamic Responses
時間枠:T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

Changes in motor-area hemodynamic responses during motor tasks are assessed using functional near-infrared spectroscopy (fNIRS)

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
Changes in Upper- and Lower-Limb EMG Activity and Muscle Synergies
時間枠:T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

Changes in target-muscle activation, active contribution, abnormal muscle synergies, co-contraction, and interlimb temporal coupling are assessed using upper- and lower-limb electromyography (EMG)

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
Changes in Electrodermal Responses and Stimulation Tolerability
時間枠:T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), including assessments during the 4-week intervention period

Electrodermal responses and stimulation tolerability are evaluated using electrodermal signals and records of stimulation-related discomfort

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), including assessments during the 4-week intervention period
Changes in Upper- and Lower-Limb Kinematics and Coordination
時間枠:T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).

Changes in movement speed, smoothness, trajectory deviation, joint range of motion, gait or pedaling symmetry, and interlimb coordination are assessed

T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
BCI Decoding and Closed-Loop Control Performance
時間枠:From initial BCI calibration (T0, 1-2 weeks before surgery) to end of intervention week 4 (T3), with follow-up assessment at T4 (4 weeks after SCS electrode removal)

BCI performance is evaluated using decoding accuracy, valid trigger rate, false trigger rate, control latency, robotic task completion rate, assistance level, and online model stability

From initial BCI calibration (T0, 1-2 weeks before surgery) to end of intervention week 4 (T3), with follow-up assessment at T4 (4 weeks after SCS electrode removal)
Safety, Training Completion, and Data Acquisition Quality
時間枠:During the 4-week intervention after SCS implantation, with final assessment at T4 (4 weeks after SCS electrode removal)

SCS-, BCI-, and robotic device-related adverse events, training completion, device tolerability, and the completeness and quality of synchronized upper- and lower-limb data acquisition are recorded

During the 4-week intervention after SCS implantation, with final assessment at T4 (4 weeks after SCS electrode removal)
Change in Berg Balance Scale Score
時間枠:T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

Balance function is assessed using the Berg Balance Scale.

T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

協力者

捜査官

  • 主任研究者:Feng Jin, MD、Qingdao Central Hospital, University of Health and Rehabilitation Sciences

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年10月21日

一次修了 (推定)

2027年9月30日

研究の完了 (推定)

2028年3月31日

試験登録日

最初に提出

2026年10月22日

QC基準を満たした最初の提出物

2026年11月10日

最初の投稿 (実際)

2026年11月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月17日

QC基準を満たした最後の更新が送信されました

2026年11月10日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • KY202614801

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data will not be shared with external researchers. Study data will be used for analyses within this research project. Study findings will be reported in aggregate form while protecting participant privacy

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。